|
Prognostic significance of the CP-GEP assay combining clinicopathologic factors and gene expression profiling in patients (pts) with AJCC v8 stage I/II cutaneous melanoma (CM). |
|
Teresa Maria Santos Amaral |
Honoraria - CeCaVa; Novartis |
Consulting or Advisory Role - CeCaVa |
Research Funding - NeraCare GmbH (Inst); Novartis (Inst); Sanofi (Inst); Skyline Diagnostics (Inst) |
|
|
Research Funding - Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Novartis (Inst) |
|
|
Consulting or Advisory Role - MSD; Novartis; Roche; Sanofi; Sun Pharma |
Research Funding - MSD (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; CeGaT; MSD Oncology; Novartis; Roche Pharma AG |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche Pharma AG |
Research Funding - Stiftung Immunonkologie/Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche |
|
|
No Relationships to Disclose |
|
|
Employment - Skyline Diagnostics |
Stock and Other Ownership Interests - Skyline Diagnostics |
|
|
Employment - Skyline Diagnostics |
|
|
Employment - Skyline Diagnostics |
Stock and Other Ownership Interests - Skyline Diagnostics |
Research Funding - Skyline Diagnostics |
|
|
Stock and Other Ownership Interests - IO Biotech; RiverD; Skyline Diagnostics |
Honoraria - Agenus; BIOCAD; BIOINVENT; BioNTech; CatalYm; Ellipses Pharma; GlaxoSmithKline; IO Biotech; ISA Pharmaceuticals; Merck; MSD; NEKTAR; Novartis; Pfizer; Sairopa; Sellas Life Sciences; Skyline Diagnostics |
Consulting or Advisory Role - Agenus; BioCad; BIOINVENT; CatalYm; Ellipses Pharma; GlaxoSmithKline; IO Biotech; IO BIOTECH; ISA Pharmaceuticals; Merck; MSD; NEKTAR; Novartis; Pfizer; Sairopa; Sellas Life Sciences; Skyline Diagnostics |
Speakers' Bureau - BIOCAD; Bristol-Myers Squibb.; Merck; MSD |
|
|
Stock and Other Ownership Interests - Hookipa Pharma |
Honoraria - Bristol-Myers Squibb; Novartis; Sanofi |
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Sanofi |
Research Funding - Hookipa Pharma (Inst) |
Patents, Royalties, Other Intellectual Property - Hookipa Pharma |
|
|
Honoraria - Kyowa Kirin; Takeda |
Research Funding - BioNTech (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst) |